29/01/2021 - 15:05

PharmAust chasing dogs for anti-cancer drug trial

29/01/2021 - 15:05

Bookmark

Save articles for future reference.

ASX-listed clinical-stage biotech group, PharmAust has put out a call to pet owners who have dogs with B-cell lymphoma to allow their pets to participate in a Phase IIb trial to help the company evaluate its newly formulated anti-cancer drug Monepantel. PharmAust says recent trials have shown the drug is a safe and effective treatment for dogs that have not undergone any treatment for this type of cancer.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options